NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
about
Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and InhibinThe expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factorRegulation of osteoclast differentiationMaintenance of Bone Homeostasis by DLL1-Mediated Notch SignalingGeneration and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues.WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand.RANKL signaling and osteoclastogenesis is negatively regulated by cardamonin(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.NF-κB-Mediated Regulation of OsteoclastogenesisPlumbagin inhibits osteoclastogenesis and reduces human breast cancer-induced osteolytic bone metastasis in mice through suppression of RANKL signalingMutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast FunctionPaget disease of bone.Signaling networks that control the lineage commitment and differentiation of bone cells.CD44 deficiency inhibits unloading-induced cortical bone loss through downregulation of osteoclast activity.NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factorOsteoclast fusion and regulation by RANKL-dependent and independent factors.Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclastsMurine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2Dimorphic effects of Notch signaling in bone homeostasis.RAGE mRNA expression and its correlation with nuclear factor kappa beta mRNA expression in inflamed human periradicular tissues.Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation.Functions of nuclear factor kappaB in bone.Lymphangiogenesis, myeloid cells and inflammation.12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.Suppression of NF-κB activation by gentian violet promotes osteoblastogenesis and suppresses osteoclastogenesis.Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling.Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells.D-chiro-inositol negatively regulates the formation of multinucleated osteoclasts by down-regulating NFATc1.Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State.Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK.Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells.Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism.VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity.Stimulation of macrophage TNFalpha production by orthopaedic wear particles requires activation of the ERK1/2/Egr-1 and NF-kappaB pathways but is independent of p38 and JNK.Secretion of cytokines and growth factors as a general cause of constitutive NFkappaB activation in cancer.Aspirin inhibits LPS-induced macrophage activation via the NF-κB pathway.Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors.Hyperbaric oxygen therapy modulates serum OPG/RANKL in femoral head necrosis patients.Relationship between osteoporosis and expression of Bcl-2 and CXCL12.
P2860
Q24633744-E187E527-FD43-4F74-B568-D89298DABA8AQ28274046-07C4BC23-5575-4FF5-BA7C-EDBFE4909BF4Q28593319-22A10BAC-A352-4555-9D8B-6D5A8E7F6A58Q33835628-77030433-35B6-4CBF-8675-5C3980D7948DQ34159764-58E9B32C-CA65-41B8-AB95-D4602C4B7FF6Q34241611-174579C0-CDF9-4DCD-A82F-AC977CD592DAQ34731280-3C8954B1-8144-432B-A40E-BFBD88BAFA03Q35233222-3E685525-D5AA-4E57-B428-79ED09AC561AQ35260971-1F5CDE15-73C2-4513-9AB2-4E1A418C2874Q35751362-F16B4A0D-F25B-4366-B27E-24BBA87F808EQ35953074-EE739101-564B-4E01-8C63-BC4BB13759D0Q36029217-4069EFD0-7D90-4B5D-825C-F00ECF753319Q36082866-B365F817-2551-4B01-90F3-62D10795DB8EQ36245921-900AF787-AF4A-42BB-8FE8-B22FF9082367Q36401969-78AB58A8-66AB-4ACB-B014-CA7D7344BD95Q36568536-8E155E09-A0F6-4BF8-95F3-1CBFA5BC0D1EQ36733053-2426A48E-32A2-481E-986F-D7F603EB4554Q37085639-F87CA0E8-C564-450E-9153-77E3AD4867E5Q37165102-D074D46D-5960-43B4-B8AC-E0638131941CQ37199673-6C091900-2525-4FC0-8661-08DE7D2D9882Q37201872-3E0AEB1E-EE27-401C-99D6-9970D36B5ABEQ37730952-DD4F372D-19EB-4516-886E-35C0611E87E1Q37754580-7CEDF5AC-846F-40AA-B16A-86A35D11F340Q38346899-FF6BFCAD-7BD4-4294-BFD7-554F0AAFBCB3Q38972321-91D8E44A-25FE-4ACB-B337-9FE4F1F6802DQ39028702-4791DDBD-A647-4FD6-9C6A-1F06F678213CQ39066528-540907C1-D5FA-453F-ACC5-AEC6AA5B497DQ39328894-A2152FB7-559A-4868-B93F-B3E75173B6F9Q39445928-8D077B53-F766-4E4D-B5F9-441B82A708E4Q39451512-B72D5E4F-FE61-440C-AAC2-A9C196361025Q39607279-3BFCD656-4880-402E-A2FD-C72E69CD819DQ39646430-3F52CCBF-2A20-406E-B3A6-3C28B81E05BCQ39647223-09475B7D-EE02-40E7-8D39-83D3C2DEA2E8Q39812715-5F976C9F-7B90-4BCA-A89D-B95C7E44CE78Q39957832-3F821DCC-FEEC-45FB-BF98-0C2A933BF633Q40607151-CFB44DB8-B37F-477C-9FCD-659B31F8D5BDQ41051290-BB993A44-1A4C-470C-9CCE-92045FE7305EQ45151645-A9AED095-C368-4E42-A8C1-810D559CC5C9Q47310464-F85C530F-913B-43E9-BCEA-87866E771C74Q49402376-0D391E0B-6E1B-4C16-B875-2667C0E2FA88
P2860
NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
NF-kappaB p50 and p52 expressi ...... e-mediated osteoclastogenesis.
@en
NF-kappaB p50 and p52 expressi ...... e-mediated osteoclastogenesis.
@nl
type
label
NF-kappaB p50 and p52 expressi ...... e-mediated osteoclastogenesis.
@en
NF-kappaB p50 and p52 expressi ...... e-mediated osteoclastogenesis.
@nl
prefLabel
NF-kappaB p50 and p52 expressi ...... e-mediated osteoclastogenesis.
@en
NF-kappaB p50 and p52 expressi ...... e-mediated osteoclastogenesis.
@nl
P2093
P1476
NF-kappaB p50 and p52 expressi ...... e-mediated osteoclastogenesis.
@en
P2093
Brendan F Boyce
Lianping Xing
Louise Carlson
Mehrdad Tondravi
Timothy P Bushnell
Ulrich Siebenlist
Zhenxing Tai
P2860
P304
P356
10.1359/JBMR.2002.17.7.1200
P577
2002-07-01T00:00:00Z